-
Combination Products
-
Fiscal Year 2008
FY 2008 OCP Review Performance:
Formal Requests for Designation Submitted by Industry
October 1, 2007 – September 30, 2008
| RFDs Pending Beginning of Period | 10 |
| Original RFDs Submitted | 86 |
| Requests for Reconsideration Submitted | 4 |
| RFDs Withdrawn by Sponsor | 6 |
| RFDs Not Filed (Incomplete) | 46 |
| Pending at End of Period (Not Overdue) | 5 |
| Total Decisions Issued* | 43 |
DECISIONS ISSUED |
Combination Products |
Non-Combination Products |
Total |
|---|---|---|---|
| CBER |
2 total: 2 device/biologic |
7 total: 1 drug/biologic reconsideration |
9 |
| CDER |
15 total: 1 drug/biologic 13 drug/device 1 drug/device reconsideration |
10 total: 2 drug reconsiderations |
25 |
| CDRH | 6 total: 6 drug/device |
3 total: 3 device |
9 |
| RFD Decisions Issued | 22 | 17 | 39 |
| Responses to Requests for Reconsideration Issued | 1 | 3 | 4 |
| Total | 23 | 20 | 43 |
| Mean Total Review Time† | 57.4 days | 56.2 days | 56.9 |
| Median Total Review Time† | 59 days | 58 days | 58 |
| Rangeof Total Review Time† | 36-60 days | 28-60 days | 28-60 |
†Based on original RFD decisions. Requests for Reconsideration are responded to within a 15 day timeframe as required by 21 CFR 3.8(c).
*Includes Original RFDs and Requests for Reconsideration
-
-

